GFR Estimation, Cockcroft

M 90-139 ml/min; F 80-125 ml/min

Estimates creatinine clearance from age, weight, sex, and serum creatinine as a surrogate for GFR.

kglbs
mg/dLumol/L
Gender
Female+0.85Male+1
yrs

Indications for Use

Used to estimate creatinine clearance for drug dosing when pharmacokinetic data were historically based on this measure, particularly for renally cleared or narrow‑therapeutic‑index agents (chemotherapy, antibiotics) 1 [Level I evidence].
Clinically useful when measured GFR is unavailable, especially in stable adults, including oncology settings where CG showed low bias vs measured GFR for carboplatin dosing 2 [Level II evidence].

Insights & Cautions

Adjust dose estimates cautiously because creatinine reflects muscle mass: this method overestimates GFR in sarcopenia and cirrhosis (KDIGO 2024 1) and underestimates in obesity or edema due to weight distortion. Accuracy is poor in cancer, critical illness, and AKI, where mGFR is preferred. For drugs with narrow therapeutic ranges, KDIGO recommends eGFRcr‑cys or mGFR instead of this estimate (KDIGO 2024 1).